NBIX Latest Quarter’s Earnings
Announce Date11/2/2026
EPS Actual (USD)2.03
Revenue Actual (USD)1.12B
Neurocrine Biosciences Inc Earnings Dates & Reports
This page offers detailed Neurocrine Biosciences Inc earnings data including the latest Neurocrine Biosciences Inc earnings report, the upcoming Neurocrine Biosciences Inc earnings date, historical data and Neurocrine Biosciences Inc earnings call news.
NBIX Upcoming Quarter's Earnings
Announce Date--
EPS Forecast (USD)--
Revenue Forecast (USD)--
NBIX FY2025 Earnings
EPS (YoY)4.8141.50%
Revenue (YoY)2.86B21.45%
Neurocrine Biosciences Inc (NBIX) Earnings History
| Release Date | Period End | EPS/Forecast | Revenue/Forecast | EPS Surprise % | Revenue Surprise % |
|---|---|---|---|---|---|
| 11/2/2026 | 09/2026 | 2.03/1.91 | 1.12B/1.04B | 6.45% | 7.64% |
| 7/30/2026 | 06/2026 | 1.43/1.34 | 959.00M/885.80M | 6.51% | 8.26% |
| 5/5/2026 | 03/2026 | 1.97/1.17 | 814.50M/772.58M | 67.68% | 5.43% |
| 2/11/2026 | 12/2025 | 1.54/1.88 | 805.50M/791.96M | -18.40% | 1.71% |
| 10/28/2025 | 09/2025 | 2.11/1.59 | 794.90M/746.52M | 32.89% | 6.48% |
| 7/30/2025 | 06/2025 | 1.09/0.97 | 687.50M/652.61M | 11.80% | 5.35% |
| 5/5/2025 | 03/2025 | 0.08/0.55 | 572.60M/562.17M | -85.47% | 1.86% |
| 2/6/2025 | 12/2024 | 1.03/1.56 | 627.70M/628.99M | -33.80% | -0.20% |
Neurocrine Biosciences Inc Latest Earnings Call Transcripts
Neurocrine Biosciences (NBIX) Q3 2026 Earnings Call: INGREZZA Guidance Raised
Neurocrine Biosciences Q3 2026 sales topped $1.1 billion as INGREZZA reached $801 million. Management raised full-year INGREZZA guidance.